My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

0.8000 +0.0490 (+6.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mainz Biomed N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer ↗

December 29, 2023

During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc.

Via Benzinga

Is This BioTech Play Severely Undervalued? BioTech Shares Promising Results From Colorectal Study ↗

December 19, 2023

Via Benzinga

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 05, 2023

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 05, 2023

Via Benzinga

The Latest Analyst Ratings for Mainz Biomed ↗

November 20, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Mainz Biomed ↗

September 26, 2023

Via Benzinga

While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer ↗

December 05, 2023

Obesity has been linked to development of a range of diseases and unfortunately, cancer. More specifically, the National Cancer Institute estimated that colorectal cancer is 1.3 times more likely in...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 14, 2023

Via Benzinga

Crude Oil Gains Over 1%; US Budget Deficit Narrows For October ↗

November 13, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500...

Via Benzinga

Topics Stocks

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 13, 2023

Via Benzinga

Why Mainz Biomed (MYNZ) Stock Is Getting Hammered ↗

November 13, 2023

Mainz Biomed NV (NASDAQ: MYNZ) shares are trading lower by 46% to $1.21 during Monday's session has entered a securities purchase agreement with institutional investors to raise $5 million through a

Via Benzinga

Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher ↗

November 13, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...

Via Benzinga

Topics Stocks

US Stocks Fall; Tyson Foods Posts Upbeat Earnings ↗

November 13, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening Test ↗

November 13, 2023

The integration of Artificial Intelligence (AI) in biotechnology is rapidly gaining momentum, revolutionizing the field of life sciences. AI technologies, such as machine learning and deep learning...

Via Benzinga

Topics Artificial Intelligence

Mainz Biomed’s (NASDAQ: MYNZ) ColoFuture Study Reveals “Groundbreaking Results”: ColoAlert® Raises The Bar For Colorectal Cancer Detection

November 08, 2023

--News Direct--

Via News Direct

Topics Death

AI Meets Oncology! Mainz Biomed Inks Pact With Liquid Biosciences To Develop Next-Gen Colorectal Cancer Screening Test ↗

November 07, 2023

Mainz Biomed N.V. (NASDAQ: MYNZ) inked a pact with Liquid Biosciences, a bio-analytics company leveraging its proprietary AI analysis technology platform (EMERGE), to enhance the

Via Benzinga

Topics Artificial Intelligence

BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test ↗

November 07, 2023

On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report.

Via Benzinga

Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection ↗

November 07, 2023

Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer.

Via Benzinga

Splunk Layoffs 2023: What to Know About the Latest SPLK Job Cuts ↗

November 01, 2023

Splunk layoffs are on the way for 7% of the cybersecurity company's global employees as it continues a restructuring plan.

Via InvestorPlace

Topics Workforce

Why Is WeWork (WE) Stock Down 38% Today? ↗

November 01, 2023

WeWork stock is falling on Wednesday as investors in WE shares react to reports that the company is considering a bankruptcy filing.

Via InvestorPlace

Topics Bankruptcy

Why Is Paycom Software (PAYC) Stock Down 39% Today? ↗

November 01, 2023

Paycom Software stock is falling hard on Wednesday as investors in PAYC go over the company's mixed earnings report for Q3 2023!

Via InvestorPlace

Why Is Mainz Biomed (MYNZ) Stock Moving Today? ↗

November 01, 2023

Mainz Biomed stock is on the move Wednesday as investors in MYNZ react to results from a colorectal cancer screening test campaign.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 01, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!

Via InvestorPlace

Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results ↗

October 31, 2023

As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter.

Via Benzinga

Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine ↗

October 17, 2023

Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...

Via Benzinga

Big Pharma Could Transform Into BioTech Pharma ↗

October 10, 2023

As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...

Via Benzinga

Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe ↗

October 04, 2023

While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated.

Via Benzinga

Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine ↗

September 27, 2023

Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.